SyMRI NEURO

SyntheticMR
The product package SyMRI NEURO includes contrast weighted images as well as biomarker segmentation, volumetric measurements of brain tissues and parametric maps. The product is designed to offer the clinician more information than conventional MRI and provide objective decision support for the diagnosis and follow-up of patients.
Information source: Public
Last updated: Jan. 30, 2020

General Information

General
Product name SyMRI NEURO
Company SyntheticMR
Subspeciality Neuro
Modality MR
Disease targeted Multiple sclerosis, atrophy, dementia, neurogenerative diseases
Key-features Contrast image synthesis, brain region segmentation, degree of myelination,
Suggested use

Technical Specifications

Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time

Regulatory

Certification
CE
Certified, Class IIa , MDD
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since 04-2017
Distribution channels GE Healthcare, Siemens Healthineers (syngo.via and marketplace)
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers